期刊文献+

Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells 被引量:3

Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells
暂未订购
导出
摘要 AIM: To investigate the importance of direct contact between Kupffer cells (KCs) and hepatocytes (HCs) during hepatic inflammatory responses, and the effect of leflunomide's active metabolite, A771726, on cytokines in KCs, HCs and KC cocultures (DC cocultures). METHODS: KCs and HCs in liver were isolated by digestion with pronase and collagenase. Lipopolysaccharide (LPS)-induced inflammatory response in monocultures of rat HCs and KCs was compared with that in DC cocultures. Tumorn ecrosis factor-α (TNF-α) and interleukin-1 (IL-1) concentrations in different culture supernatants were measured with ELISA. TNF-α mRNA in KCs of inflammatory liver injury was analyzed with reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: DC cocultures strongly exhibited the production of TNF-α and IL-1 compared with other cultures, and these cytokines were mainly produced by KCs, especially byactivated KCs. Time course studies revealed an increased production of TNF-α preceding the IL-1 production, suggesting that increased TNF-α levels could be involved in the increase of IL-1 production. Leflunomide's active metabolite, A771726, had significantly inhibitory effect on TNF-α and IL-1 at protein and transcription levels, and the reduced production of IL-1 by A771726 was associated with the inhibitory action of A771726 on TNF-α. CONCLUSION: Leflunomide can inhibit hepatoolte damage by inhibiting proinflammatory cytokine release from KCs. AIM: To investigate the importance of direct contact between Kupffer cells (KCs) and hepatocytes (HCs) during hepatic inflammatory responses,and the effect of leflunomide's active metabolite,A_(771726),on cytokines in KCs,HCs and KC cocultures (DC cocultures). METHODS: KCs and HCs in liver were isolated by digestion with pronase and collagenase.Lipopolysaccharide (LPS)- induced inflammatory response in monocultures of rat HCs and KCs was compared with that in DC cocultures.Tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) concentrations in different culture supernatants were measured with ELISA.TNF-α mRNA in KCs of inflammatory liver injury was analyzed with reverse transcriptase polymerase chain reaction (RT-PCR). RESULTS: DC cocultures strongly exhibited the production of TNF-α and IL-1 compared with other cultures,and these cytokines were mainly produced by KCs,especially by activated KCs.Time course studies revealed an increased production of TNF-α preceding the IL-1 production, suggesting that increased TNF-α levels could be involved in the increase of IL-1 production.Lefiunomide's active metabolite,A_(771726),had significantly inhibitory effect on TNF-α and IL-1 at protein and transcription levels,and the reduced production of IL-1 by A_(771726) was associated with the inhibitory action of A_(771726) on TNF-α. CONCLUSION: Leflunomide can inhibit hepatocyte damage by inhibiting proinflammatory cytokine release from KCs.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第11期1608-1611,共4页 世界胃肠病学杂志(英文版)
基金 Supported by Natural Science Foundation of Anhui Province,No.98446733
  • 相关文献

参考文献3

二级参考文献6

共引文献23

同被引文献11

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部